Drug profile · INN
siltuximab
SYLVANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
siltuximab (SYLVANT) is an FDA-listed pharmaceutical active ingredient. Associated with Recordati Rare Diseases Australia Pty.. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN siltuximab
Brand SYLVANT
Route INJECTION
Formulation INJECTABLE
ATC code L04AC11
Originator Recordati Rare Diseases Australia Pty.
Frequently asked questions
What is siltuximab?
siltuximab (SYLVANT) is an FDA-listed pharmaceutical active ingredient. Associated with Recordati Rare Diseases Australia Pty.. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for siltuximab?
SYLVANT is a marketed brand name for siltuximab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of siltuximab?
siltuximab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.